S&P Biotech SPDR (NY: XBI )
88.21 UNCHANGED Streaming Delayed Price Updated: 8:00 PM EDT, Jun 7, 2023 Add to My Watchlist
Headline News about S&P Biotech SPDR
Can Biotech Stocks Continue Rallying In This Bear Market?
October 31, 2022
Bluebird bio Seeks Back-to-Back Nods, 'Go' or 'No-Go' For Revance's Botox Rival, Amylyx' Twin Hurdles And More: September's Key PDUFA Catalysts Biotech Investors Must Know
August 31, 2022
After August’s mixed tally for Food and Drug Administration approvals, investors turn to a new month, which has a fairly loaded calendar.
The SPDR S&P Biotech ETF remains our key indicator for small cap biotechs. It is up 14.55% over one month at $93.78 but is still down 16% YTD. The Russell 2000 is up 16.5% over one month mirroring...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following